Naltrexone is most commonly used for the treatment of opioid use disorder (OUD) and alcohol use disorder (AUD). It is an opioid receptor antagonist, meaning it attaches to opioid receptors without activating them. This blocks the effects of opioids such as heroin, fentanyl, or prescription painkillers, so taking these substances while on naltrexone does not produce the usual “high.” For people with alcohol dependence, naltrexone can reduce the pleasurable effects of drinking and help decrease cravings, supporting long-term recovery efforts.
Unlike opioid substitution therapies such as methadone or buprenorphine, naltrexone does not act as a replacement opioid. It is non-addictive, does not cause physical dependence, and does not lead to withdrawal when stopped. This makes it particularly attractive for individuals who want a non-opioid, non-controlled medication to support abstinence. Naltrexone is typically used alongside counseling, behavioral therapy, peer support groups, and lifestyle changes, rather than as a stand-alone cure. When incorporated into a comprehensive treatment plan, it can significantly lower relapse risk and improve quality of life.
Another emerging, off-label use for naltrexone is in very low doses (called low-dose naltrexone, or LDN) for certain chronic pain conditions, autoimmune diseases, and inflammatory disorders. In these cases, the doses are much smaller than those used for addiction treatment and are intended to gently modulate the immune system and reduce inflammation. While some patients report benefits for conditions like fibromyalgia, multiple sclerosis, or Crohn’s disease, this use is still considered experimental and should only be pursued under the guidance of a knowledgeable healthcare provider. HealthSouth East Valley Rehabilitation Hospital can help evaluate whether naltrexone is appropriate for your specific condition and goals.
The typical oral naltrexone dose for opioid or alcohol use disorder in adults is 50 mg once daily, but the exact dosage regimen can vary. Some patients may be started on a lower dose and gradually increased to minimize side effects, especially if they are sensitive to medications or have liver concerns. Alternative dosing schedules—such as 100 mg every other day or 150 mg every third day—may be used in certain situations to improve adherence, though daily dosing is the most common and straightforward approach.
Naltrexone should only be started after opioids are fully cleared from the body to avoid precipitated withdrawal, which can be severe. For short-acting opioids, this usually means waiting at least 7–10 days after the last dose; for long-acting opioids or methadone, the waiting period can be longer. Before initiation, many providers use a naloxone challenge test or confirm opioid abstinence with a urine drug screen. For alcohol use disorder, patients should ideally have abstained from alcohol for several days and completed any necessary detoxification before beginning therapy. HealthSouth East Valley Rehabilitation Hospital follows structured protocols to ensure naltrexone is started safely.
Naltrexone tablets are taken by mouth with or without food, usually at the same time each day to help build a consistent routine. Taking the tablet with food can reduce nausea in patients who experience gastrointestinal upset. For extended-release injectable naltrexone, a 380 mg intramuscular injection is administered once every four weeks by a trained healthcare provider. This long-acting form can be helpful for patients who have difficulty remembering daily pills or who prefer the added assurance of a sustained medication effect. Patients should never attempt to adjust their dose or stop naltrexone abruptly without consulting a clinician, as sudden changes in opioid tolerance can increase overdose risk if relapse occurs.
Before starting naltrexone, a thorough medical evaluation is essential. Because the medication is processed by the liver, baseline liver function tests (LFTs), including AST and ALT, are typically performed. Naltrexone is generally avoided or used with great caution in patients with acute hepatitis or significant liver impairment. Your clinician will ask about your history of liver disease, hepatitis B or C, heavy alcohol use, and use of other medications that may be hard on the liver. Ongoing monitoring is recommended during treatment to catch any emerging liver issues early.
It is also crucial to ensure that you are free from physical opioid dependence before taking your first dose. Using naltrexone while opioids are still in your system can trigger sudden, intense withdrawal symptoms—known as precipitated withdrawal. This includes people using prescribed opioid pain medications, illicit opioids, or certain opioid-containing cough syrups. You must inform your provider about all opioid use, even if it is intermittent, and follow the recommended opioid-free interval. Patients should carry a medical alert card or bracelet indicating they are taking naltrexone, so emergency providers know that standard opioid pain relief will be less effective.
Naltrexone may not be ideal for everyone. People who anticipate needing opioid pain medication for surgery, serious injury, or chronic pain management must discuss alternative strategies with their medical team well in advance. Pregnant or breastfeeding individuals should talk carefully with their providers about the risks and benefits of naltrexone versus continued substance use or other treatments. Additionally, mental health status should be reviewed, as untreated depression or other psychiatric conditions can complicate recovery. At HealthSouth East Valley Rehabilitation Hospital, patients receive a comprehensive assessment to identify these issues and create a safe, individualized care plan.
Certain medical conditions and situations make naltrexone unsafe or inappropriate. The primary contraindication is current physical dependence on opioids or ongoing opioid use, including maintenance therapies like methadone or buprenorphine. Because naltrexone blocks opioid receptors, giving it to someone who still has opioids in their system can precipitate severe withdrawal requiring urgent medical care. For similar reasons, patients who are unable or unwilling to remain abstinent from opioids are not good candidates for this medication.
Naltrexone is also contraindicated in patients with acute hepatitis or severe liver failure. The medication can stress the liver, especially at higher doses, so people with existing serious liver disease face an elevated risk of worsening their condition. A history of hypersensitivity or allergic reaction to naltrexone or any component of the formulation is another clear contraindication. Signs of an allergic reaction can include rash, itching, swelling, severe dizziness, or difficulty breathing, and immediate medical attention is required if these occur.
Caution is advised in other special populations, and in some cases naltrexone may be deferred or used only under close supervision. This includes individuals with significant renal impairment, uncontrolled psychiatric illness, or concurrent use of medications with known liver toxicity. For pregnant patients, evidence is evolving, and decisions are made on a case-by-case basis, weighing the risks of untreated opioid or alcohol use against potential fetal exposure. HealthSouth East Valley Rehabilitation Hospital carefully screens for these contraindications before initiating treatment to minimize risk and maximize safety for every patient.
Many people tolerate naltrexone well, but like all medications, it can cause side effects. Common, usually mild reactions include nausea, headache, dizziness, fatigue, anxiety, and trouble sleeping. Gastrointestinal issues such as stomach cramps, decreased appetite, or diarrhea may also occur, particularly when first starting the medication. These symptoms often improve over time as the body adjusts. Taking the tablet with food and staying well hydrated can lessen digestive discomfort.
Less commonly, naltrexone can affect mood and mental health. Some patients report irritability, low mood, or increased feelings of depression. Any emergence or worsening of suicidal thoughts, profound sadness, or sudden behavioral changes should be taken seriously and reported immediately to a healthcare provider. Liver-related side effects, although rare at standard doses, are more serious. Signs of liver injury include persistent nausea, extreme fatigue, dark urine, yellowing of the skin or eyes (jaundice), or pain in the upper right side of the abdomen. If these symptoms appear, naltrexone should be stopped and urgent medical evaluation is necessary.
For those receiving injectable naltrexone, localized reactions at the injection site are possible. Redness, tenderness, swelling, bruising, or a small lump may appear where the shot was given, usually resolving within a few days. Very rarely, a severe injection-site reaction or tissue damage can develop. Patients should contact their clinician if they notice intense pain, significant swelling, hardening of the skin, open sores, or signs of infection such as warmth, pus, or fever. At HealthSouth East Valley Rehabilitation Hospital, patients are counseled on what to expect, how to manage mild side effects at home, and when to seek prompt medical care.
Naltrexone’s most clinically significant interactions involve opioid-containing medications. Because it blocks opioid receptors, any drug that relies on those receptors for pain relief or cough suppression will be less effective or completely ineffective. This includes common prescription painkillers such as oxycodone, hydrocodone, morphine, codeine, tramadol, and combination products with acetaminophen, as well as some cough syrups and anti-diarrheal agents containing opioids. Attempting to “override” naltrexone by taking large amounts of opioids is extremely dangerous and can lead to life-threatening overdose once the naltrexone effect diminishes.
Caution is also warranted with other medications that can strain the liver. Certain antifungal drugs, antiepileptics, antituberculosis medications, and high doses of acetaminophen may increase the risk of liver injury when combined with naltrexone. Alcohol use itself is a major factor in liver health, particularly in people being treated for alcohol use disorder, so continued heavy drinking while on naltrexone further raises the risk. Your healthcare provider will review your full medication list—including over-the-counter drugs, herbal supplements, and vitamins—to identify possible interactions and adjust doses or monitoring accordingly.
Non-opioid pain relievers such as NSAIDs (ibuprofen, naproxen), acetaminophen in usual doses, certain antidepressants, anti-anxiety medications, and most blood pressure or diabetes medications generally do not directly interfere with naltrexone’s blocking action. Still, individual situations vary, especially in patients with complex medical histories. At HealthSouth East Valley Rehabilitation Hospital, clinicians will coordinate with your other healthcare providers, when needed, to ensure that your entire treatment regimen remains safe, effective, and compatible with naltrexone therapy.
If you miss a dose of oral naltrexone, take it as soon as you remember, unless it is almost time for your next scheduled dose. In that case, skip the missed dose and return to your normal dosing schedule. Do not double up or take extra tablets to “make up” for a missed dose, as this increases the risk of side effects without improving effectiveness. Maintaining a consistent daily routine—such as taking the medication with breakfast—can help reduce missed doses and keep the blocking effect stable.
Missing multiple doses in a row can reduce the protective benefits of naltrexone and may increase the risk of relapse, especially during stressful periods or high-risk situations. If you have missed several doses, contact your healthcare provider for advice. They may want to review your recent substance use, ensure no opioids have been taken, and decide whether any re-initiation protocol is needed. Never restart naltrexone on your own after a prolonged gap if you have used opioids in the meantime, as this may precipitate withdrawal.
For patients using extended-release injectable naltrexone, the timing of the next injection is important. If you miss an appointment for your monthly shot, reschedule as soon as possible. There is some flexibility in the dosing window, but long delays could leave you partially unprotected. The care team at HealthSouth East Valley Rehabilitation Hospital can help you plan ahead for travel, work schedules, and other life events to keep your dosing on track and support adherence to your treatment plan.
Naltrexone itself has a relatively wide safety margin, and overdose from the medication alone is uncommon when taken as prescribed. However, taking more than the recommended dose can increase the likelihood and severity of side effects such as nausea, vomiting, abdominal pain, dizziness, agitation, or drowsiness. In very high doses, there is a higher risk of liver toxicity, which can lead to serious complications if not promptly recognized and treated. If you or someone else has taken a large amount of naltrexone, contact a poison control center or seek emergency medical care immediately.
A more subtle overdose-related concern with naltrexone is the risk of opioid overdose in the context of relapse. Because naltrexone blocks opioid effects, some individuals may attempt to take large doses of opioids to overcome the blockade. Once naltrexone levels fall or a dose is missed, the opioids already taken—or a person’s usual amount—may suddenly become far more potent, especially after a period of abstinence that has lowered tolerance. This scenario can lead to respiratory depression and fatal overdose. Education about this risk is a critical part of any naltrexone program.
In an emergency situation involving suspected overdose—whether from naltrexone, opioids, alcohol, or other substances—call emergency services right away. If opioids may be involved, administering naloxone (Narcan) as soon as possible can be lifesaving, even in someone known to be taking naltrexone, because some opioid receptors may not be fully blocked. HealthSouth East Valley Rehabilitation Hospital emphasizes overdose education, naloxone access, and safety planning as integral components of comprehensive addiction treatment.
Proper storage of naltrexone helps maintain its effectiveness and keeps it out of reach of children and pets. Oral tablets should be kept at room temperature, away from excessive heat, moisture, and direct sunlight. The bathroom medicine cabinet is not ideal because humidity can degrade medications over time. Instead, store the bottle in a dry, cool place, tightly closed, and in the original container with the label intact so that dosing instructions and expiration dates remain visible.
Extended-release injectable naltrexone must be stored according to the manufacturer’s guidelines, which typically involve controlled room temperature and protection from freezing. Because this form is administered only by healthcare professionals, patients do not usually need to manage storage at home. Nevertheless, it is important to keep any appointment reminder cards, medication guides, and educational materials in a safe place where they can be easily referenced.
As with all prescription medications, expired or unused naltrexone should be disposed of safely. Do not flush tablets down the toilet or throw them loosely into the household trash. Ask your healthcare provider or pharmacist about take-back programs or recommended disposal methods in your area. HealthSouth East Valley Rehabilitation Hospital can provide guidance on safe disposal options and help ensure that leftover medication does not pose a risk of accidental ingestion or misuse.
In the United States, naltrexone is a prescription-only medication regulated by the Food and Drug Administration (FDA). It is not classified as a controlled substance, but it cannot legally be purchased over the counter or through legitimate pharmacies without appropriate medical authorization. Federal and state laws require that a licensed healthcare provider evaluate the patient, determine medical necessity, and either write a prescription for oral naltrexone or directly order and administer injectable formulations. These safeguards are designed to ensure that the drug is used appropriately, especially given the risks associated with precipitated withdrawal and liver toxicity.
Because of these regulations, online offers to “buy naltrexone without prescription” from unverified sources often fall into legally gray or outright illegal territory, and they may expose consumers to counterfeit, contaminated, or substandard medications. Self-medicating with naltrexone, particularly in the context of ongoing opioid or alcohol use, can be dangerous. Patients may inadvertently trigger severe withdrawal, interact with other medications, or miss important medical conditions that need treatment. Safe access requires proper assessment, lab work when indicated, dose selection, education, and ongoing follow-up—all of which are difficult or impossible through unregulated channels.
HealthSouth East Valley Rehabilitation Hospital offers a legal and structured solution for acquiring naltrexone without a formal outside prescription. Instead of requiring patients to arrive with a prescription in hand, the hospital’s clinicians conduct an in-house evaluation, confirm that naltrexone is appropriate, and then initiate therapy within a supervised medical program. This model complies with U.S. prescribing laws while sparing patients the burden of arranging separate prescriptions elsewhere. It also ensures that every step—from initial assessment and dosing to monitoring, counseling, and long-term follow-up—is coordinated under one roof, providing safer, more reliable access to naltrexone for individuals committed to recovery.
Naltrexone is a medication called an opioid receptor antagonist. It works by blocking opioid receptors in the brain so that opioid drugs (like heroin, oxycodone, or morphine) cannot attach and produce their usual effects such as euphoria and pain relief. It also helps reduce cravings and the rewarding feelings associated with alcohol. By “occupying” these receptors, naltrexone reduces the likelihood that using opioids or drinking alcohol will feel pleasurable, which supports recovery from addiction.
Naltrexone is most commonly prescribed to treat alcohol use disorder and opioid use disorder. For alcohol use disorder, it helps reduce the urge to drink and the risk of heavy drinking. For opioid use disorder, it prevents opioids from producing a “high,” which can help people avoid relapse after they have fully detoxed from opioids. In some cases, low-dose naltrexone (LDN) is used off-label for certain chronic pain or autoimmune conditions, but this is not its primary approved use and should only be done under close medical supervision.
Naltrexone is available as an oral tablet and as a long-acting intramuscular injection. The oral version is usually taken once daily, though some prescribers may use flexible dosing schedules depending on the person’s pattern of drinking or drug use. The injectable form (often known by the brand name Vivitrol) is given as a deep gluteal muscle injection once every 4 weeks (about once a month). Your healthcare provider will help decide which form is more appropriate based on your medical history, lifestyle, and treatment goals.
Yes. You must be completely off opioids before starting naltrexone, including prescribed pain medicines (like oxycodone, hydrocodone, morphine, methadone) and illicit opioids (like heroin or fentanyl). If opioids are still in your system when you start naltrexone, it can precipitate sudden and severe withdrawal. Typically, people should be opioid-free for at least 7–10 days before starting naltrexone, and sometimes longer after long-acting opioids or methadone. A healthcare professional may use a urine drug test and sometimes a small “test dose” to ensure safety.
Naltrexone is most effective when used as part of a plan to reduce or stop drinking, but it can still help reduce cravings and heavy drinking episodes even if you have not yet reached complete abstinence. Some treatment plans allow people to start naltrexone while they are still drinking, with the goal of gradually reducing intake. However, for best results and safety, you should discuss your drinking patterns openly with your provider and follow their guidance on how and when to start the medication.
Common side effects of naltrexone may include nausea, headache, dizziness, fatigue, trouble sleeping, anxiety, abdominal pain, and muscle or joint aches. With the extended-release injection, people sometimes experience injection-site reactions such as pain, swelling, or bruising. Many of these side effects are mild and tend to improve over time as the body adjusts. If side effects are severe, persistent, or worrying, you should contact your healthcare provider promptly.
Naltrexone is not addictive and does not produce a “high” or euphoria. It does not cause physical dependence in the way opioids, alcohol, or benzodiazepines can. You do not experience withdrawal symptoms when stopping naltrexone itself. However, you can become physically dependent again on opioids or alcohol if you return to use. Naltrexone is best viewed as a tool that helps support behavior change, not a drug that replaces one addiction with another.
Naltrexone is processed by the liver, and it can be harmful if you have significant liver damage. It is generally not recommended in patients with acute hepatitis or liver failure. Before prescribing naltrexone, your provider will usually order blood tests to check liver function (AST, ALT, and others). During treatment, your liver tests may be checked periodically. Mild-to-moderate liver disease may not completely rule out naltrexone, but the dose and monitoring plan must be carefully tailored. Always tell your provider about any history of hepatitis, cirrhosis, or heavy alcohol use.
If you take opioids while on naltrexone, you are unlikely to feel the usual effects (pain relief, euphoria) because the receptors are blocked. Some people, frustrated by the lack of effect, may try to take very large amounts of opioids to “override” the blockade, which is extremely dangerous and can lead to overdose, especially if naltrexone levels decline or wear off. In emergencies, doctors can sometimes treat severe pain with non-opioid options or very carefully managed opioid treatment, but this must be done in a controlled medical setting.
The data on naltrexone use in pregnancy and breastfeeding are limited. In general, it is not the first-line treatment during pregnancy for opioid use disorder; medications like methadone or buprenorphine have more safety data in pregnant patients. For alcohol use disorder, the risk–benefit balance must be carefully weighed because uncontrolled drinking during pregnancy is also risky. During breastfeeding, small amounts of naltrexone may pass into breast milk, but evidence is limited. Treatment decisions should be individualized with an obstetrician, addiction specialist, and pediatrician involved.
The duration varies widely. Some people may use naltrexone for several months, while others may benefit from a year or longer, especially if they have a high risk of relapse. For alcohol use disorder, many treatment guidelines suggest at least 6–12 months of medication support. For opioid use disorder, some people stay on naltrexone as a long-term relapse prevention strategy, sometimes for years. The decision to continue or taper should be made jointly with your clinician based on stability in recovery, support systems, and personal preference.
Yes, and it is strongly recommended. Naltrexone is most effective when combined with psychosocial supports such as individual counseling, group therapy, cognitive-behavioral therapy (CBT), motivational interviewing, or mutual-help groups like SMART Recovery or 12-step programs. Medication can reduce cravings and block reinforcement, while therapy helps you build coping skills, address underlying issues, and reshape your lifestyle to support lasting recovery.
Low-dose naltrexone (LDN) usually refers to doses around 1.5–4.5 mg per day, much lower than the standard 50 mg tablet dose for addiction treatment. LDN is used off-label by some clinicians for conditions like fibromyalgia, chronic pain, inflammatory bowel disease, or certain autoimmune conditions, based on its potential immune-modulating and anti-inflammatory effects. This use is not FDA-approved, and research is still emerging. Standard naltrexone treatment for alcohol or opioid use disorder uses much higher doses and has a different goal: blocking opioid receptors to reduce cravings and prevent relapse.
Naltrexone does not directly interact with most common antidepressants (like SSRIs, SNRIs) or many anti-anxiety medications, and they are often used together safely. However, some individuals report mood changes, anxiety, or sleep disturbances on naltrexone, which can overlap with psychiatric symptoms. It is crucial to tell your provider about all medications and supplements you are taking and to monitor any mood changes closely so your treatment plan can be adjusted as needed.
Naltrexone starts blocking opioid receptors soon after it reaches effective levels in the bloodstream. With oral tablets, this typically occurs within a few hours of the first dose. Many people notice some reduction in cravings within the first week, though full benefit may take several days to a few weeks. With the extended-release injection, the medication level rises steadily after the shot and maintains receptor blockade for about a month, often providing a more stable effect on cravings.
Naltrexone can usually be stopped abruptly without physical withdrawal symptoms because it does not cause physiological dependence. That said, stopping suddenly may increase your risk of relapse to alcohol or opioid use because the protective receptor blockade and craving reduction are removed. Always discuss plans to stop or change your dose with your provider so that you can put additional supports in place and reconsider your overall recovery plan.
Naltrexone is specifically used to help people reduce or stop drinking alcohol. While it does not make you violently ill if you drink (unlike disulfiram/Antabuse), drinking on naltrexone is generally discouraged because alcohol still affects your brain and body in harmful ways. The medication may help you drink less and reduce binges, but it is not a license to drink freely. The safest approach is to follow the goals you and your clinician set, whether that is complete abstinence or a structured plan to significantly reduce intake.
Most people can drive and operate machinery safely on naltrexone once they know how it affects them personally. However, because some individuals experience dizziness, fatigue, or difficulty concentrating, it is wise to see how you feel when you start the medication. If you feel sleepy, dizzy, or mentally foggy, avoid driving or using heavy equipment until those symptoms resolve or your dose is adjusted.
If you miss a dose, take it as soon as you remember on the same day. If it is almost time for your next dose, skip the missed dose and resume your regular schedule. Do not double up to “make up” for a missed dose. Missing occasional doses may reduce the effectiveness of the medication, especially for preventing impulsive drinking or opioid use, so it is important to develop reminders or routines that help you take it consistently.
Naltrexone and methadone work very differently. Naltrexone is an opioid antagonist that blocks opioid receptors and is only started after a person is completely detoxed from opioids. It does not activate the receptor and does not relieve opioid withdrawal or cravings as strongly as agonist medications for some people. Methadone is a full opioid agonist that activates the receptor in a controlled way, preventing withdrawal and reducing cravings while blocking the effects of additional opioids at higher doses. Methadone is taken daily under supervision at specialized clinics and has a long track record of reducing overdose and improving retention in treatment. Naltrexone is often best for highly motivated individuals who can maintain abstinence long enough to start it and prefer a non-opioid medication.
Naltrexone is an opioid receptor blocker used after complete detox, while buprenorphine is a partial opioid agonist that both relieves withdrawal and cravings and has a “ceiling effect” that lowers overdose risk. Buprenorphine (often combined with naloxone in Suboxone) partially activates opioid receptors, reducing cravings and stabilizing brain chemistry without the intense euphoria of full opioids. Unlike naltrexone, buprenorphine can be started while a person is still in mild to moderate withdrawal, and many people remain on it long-term. Naltrexone may appeal to those who do not want to be on any opioid medication, but it may be harder to start and maintain, and some studies show lower treatment retention compared to buprenorphine.
Naltrexone and disulfiram use very different strategies. Naltrexone reduces the rewarding effects of alcohol and helps to decrease cravings and the urge to drink heavily. Disulfiram works as a deterrent: if you drink alcohol while taking it, you develop unpleasant symptoms such as flushing, nausea, vomiting, headache, and palpitations. Disulfiram relies heavily on a person’s motivation and honesty about taking it regularly. Naltrexone tends to be better tolerated and is often preferred as a first-line medication, while disulfiram is sometimes used when a strong deterrent is desired and supervision is possible.
Both naltrexone and acamprosate are approved for alcohol dependence, but they target different systems in the brain. Naltrexone blocks opioid receptors and reduces the rewarding effects and cravings associated with alcohol. Acamprosate modulates glutamate and GABA systems to help stabilize brain activity after long-term alcohol use, which may reduce protracted withdrawal symptoms and support abstinence. Acamprosate is typically taken three times daily and is most effective for people who are already abstinent and want to maintain sobriety. Naltrexone can be helpful even when people are still drinking and trying to cut down. Choice of medication often depends on liver function, kidney function, drinking pattern, and individual response.
Someone might choose naltrexone if they want a non-opioid medication, prefer not to feel “dependent” on an opioid agonist, or have legal or occupational reasons to avoid agonist therapy. The monthly injection can be attractive for people who have trouble remembering daily pills or who want a discreet treatment option. Naltrexone may also be considered after a period of stable recovery on methadone or buprenorphine if someone wants to transition off those medications. However, it is crucial to understand that naltrexone is often less forgiving of lapses and may have lower retention in treatment, so this choice should be made carefully with a specialist.
The extended-release injection and oral tablets deliver the same active drug but in different ways. The injection provides a steady level of medication for about a month, eliminating daily adherence issues and making it harder to skip doses during moments of craving. For many people, this leads to better overall consistency and effectiveness. The oral form can be equally effective if taken reliably, and it offers more flexibility for adjusting dose or stopping quickly if side effects occur. In practice, the injection often shows higher treatment adherence and may reduce relapse more effectively for people who struggle with daily pill-taking.
Naltrexone and naloxone are both opioid antagonists, but they are used very differently. Naloxone (Narcan) is a short-acting medication used in emergencies to rapidly reverse opioid overdose. It can restore breathing within minutes and is given via injection or nasal spray. Its effect wears off quickly, often within 30–90 minutes. Naltrexone is longer-acting and used as a maintenance medication to prevent relapse, not to treat acute overdose. It is not appropriate for emergency overdose reversal because it does not act fast enough, and precipitated withdrawal can be severe if opioids are present.
Nalmefene, like naltrexone, is an opioid receptor modulator used in some countries for alcohol use disorder. It is not as widely available as naltrexone and is not approved in some regions. Nalmefene is often used “as needed” before anticipated drinking occasions to help reduce the amount consumed, whereas naltrexone is usually taken daily or via monthly injection. Both blunt the rewarding effects of alcohol, but they have slightly different receptor profiles and side effect patterns. Naltrexone remains the more commonly used and studied option in many healthcare systems.
Low-dose naltrexone (LDN) and standard-dose naltrexone use the same drug but at vastly different doses and for different purposes. Standard doses (typically 50 mg daily or 380 mg monthly injection) are used to treat alcohol and opioid use disorders by blocking opioid receptors continuously. Low doses (often 1.5–4.5 mg) are sometimes used off-label to modulate the immune system, reduce inflammation, and manage chronic pain or autoimmune conditions. At low doses, naltrexone may briefly block receptors and then lead to a rebound increase in endorphins, which is proposed to have different effects than constant blockade. The evidence base for LDN is still developing, while standard-dose naltrexone is well-established for addiction treatment.
Response to these medications varies due to differences in genetics, liver and kidney function, drinking patterns, coexisting mental health conditions, and personal preferences. Naltrexone tends to work well for people whose drinking is driven strongly by cravings and the rewarding “buzz” of alcohol. Acamprosate may benefit those who feel restless, anxious, or “off” when they stop drinking and who are already abstinent. Disulfiram can be effective in highly motivated individuals who benefit from a strong deterrent effect and may have supervised dosing. Clinicians often try one medication first, then adjust or combine treatments based on response and side effects.
